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1. Introduction
1.1. The role of traditional herbal medicine
1.1.1. Plants as source of drugs
Plants have played a significant role in maintaining human health and improving the quality of
human life for thousands of years. In the prehistoric times, people began to search for herbs from
plants which exert healing effects. Herbal medicine is based on the premise that plants contain
natural substances that can promote health and alleviate illness. The term herbs in herbal
medicine is used loosely to refer not only to herbaceous plants but also to bark, roots, leaves,
seeds, flowers and fruit of trees, shrubs and woody vines, and extracts of the same that are valued
for their savory, aromatic or medicinal qualities. Today we are witnessing a great deal of public
interest in the use of herbal remedies. The World Health Organization estimated that ≈ 80% of
the earth’s inhabitants rely on traditional medicine for their primary health care needs, and most
of this therapy involves the use of plant extracts or their active components. Furthermore, many
Western drugs had their origin in a plant extract. Reserpine, which is widely used for the
treatment of high blood pressure, was originally extracted from the plant Rauwolfia serpentina,
whereas digitalis, used as a heart stimulant, was derived from the foxglove plant (Digitalis
purpurea). The Chinese herb ephedra (Ma huang), which was used early on for the treatment of
asthma, contains the active substance ephedrine, whereas salicylic acid (a precursor of aspirin)
was obtained from willow tree bark (Salix alba) to help relieve fevers [Bruneton J, 1995].
1.1.2. Common herbal remedy
Herbal medicine is widely used today for a host of common ailments and conditions, such as
anxiety, arthritis, colds, coughs, constipation, fever, headaches, infections, insomnia, intestinal
disorders, premenstrual syndrome, stress, ulcers, and weakness. Some of the more popular herbs
2in use today include Echinacea, garlic, ginseng, goldenseal, ginkgo, saw palmetto, aloe vera, and
feverfew. Research continues with respect to the usefulness of ginger for motion sickness;
licorice for treating ulcers; hops, passionflower, and valerian for treating insomnia; feverfew for
relieving migraine headaches; peppermint oil for relieving irritable bowel syndrome; saw
palmetto berries for treating benign prostatic hypertrophy; Echinacea for its immunostimulant
properties; St John's Wort (containing hypericin) for anxiety and depression; and milk thistle
(with its rich content of flavono-lignans) for protecting and restoring liver function [Dew MJ,
1984; Tyler V, 1994 and McNutt K, 1995]. Recently, several commonly used herbs have been
identified as possessing cancer-preventive properties. These herbs include members of the Allium
sp. (garlic, onions, and chives); members of the Labiatae (mint) family (basil, mints, oregano,
rosemary, sage, and thyme); members of the Zingiberaceae family (turmeric and ginger); licorice
root; green tea; flax; members of the Umbelliferae (carrot) family (anise, caraway, celery, chervil,
cilantro, coriander, cumin, dill, fennel, and parsley); and tarragon [Caragay AB, 1992].
1.1.3. Research and new drug development of herbs
Due to the continuous increase of medical costs, many countries provide support to encourage
scientific research on alternative therapies. Furthermore, the putative efficacy of medicinal herbs
relies on empirical or anecdotal data and tradition of use, which frequently cannot satisfy the
requirements of evidence-based medicine. Thus, the step back by the analysis of traditional
herbal medicine and new drug development from herbs are started recently with high effort.
Research interest has focused on various herbs that possess hypolipidemic, antiplatelet,
antitumor, or immune-stimulating properties that may be useful adjuncts in helping reduce the
risk of various diseases. In different herbs, a wide variety of active phytochemicals, including the
flavonoids, terpenoids, lignans, sulfides, polyphenolics, carotenoids, coumarins, saponins, plant
sterols, curcumins, and phthalides have been identified [Tyler V, 1994]. Several of these
phytochemicals either inhibit nitrosation or the formation of DNA adducts or stimulate the
activity of protective enzymes such as the Phase II enzyme glutathione transferase (EC 2.5.1.18)
[Steinmetz KA, 1991; Caragay AB, 1992; Kikuzaki H, 1993; Bisset NG, 1994; Cuvelier ME,
1994; Ho CT, 1994; Huang MT, 1994; Lam LKT, 1994; Robbers JE, 1994; Zheng GQ, 1994;
Smith TJ, 1994 and Haraguchi H, 1995]. Research has centered around the biochemical activity
3of the Allium sp. and the Labiatae, Umbelliferae, and Zingiberaceae families, as well as flaxseed,
licorice root, and green tea. Many of these herbs contain potent antioxidant compounds that
provide significant protection against chronic diseases. These compounds may protect LDL
cholesterol from oxidation [Kleijnen J, 1989; Sharma RD, 1990 and 1991; Warshafsky S, 1993;
Smith TJ, 1994; Cook NC, 1996 and Manach C, 1996], inhibit lipid peroxidation [Dreosti IE,
1996 and Fuhrman B, 1997], or have antiviral or antitumor activity [Caragay AB, 1992 and
Shibata S, 1994].
In the development of medicine from plants, several steps are involved: (1) identification of
suitable plants to investigate; (2) isolation and identification of single chemical entities from the
chosen plant; (3) identification of the pharmacological actions of those entities; (4) conduct of
controlled clinical trials. The rate limiting steps appear to be (3) and (4). Many herbal medicines
are not well analyzed in terms of their mechanisms of actions, toxicity, and clinical effects.
Therein the challenge lies.
1.1.4. Safety of herbal medicine
Whereas some herbal products may be safe and may contain active constituents that have
beneficial physiologic effects, others may be unsafe to use [Tyler V, 1994]. The Food and Drug
Administration has classified several herbs as unsafe, even in small amounts, and hence they
should not be used in either foods or beverages [Larkin T, 1983 and Saxe TG, 1987]. Some herbs
are safe in modest amounts but they may become toxic at higher doses. For example, whereas
licorice root can be used safely for treating duodenal and gastric ulcers, deaths from its excessive
use have been reported. Large amounts of licorice can cause serious side effects such as
hypokalemia, high blood pressure, and heart failure [Nielsen I, 1984]. Other herbs are known to
be lethal. Germander, an herb used in some weight-loss programs, has been reported to cause
fatal hepatitis [Mostefa-Kara N, 1992]. The Chinese herbs caowu and chuanwu are used to treat
rheumatism, arthritis, bruises, and fractures. They may contain highly toxic alkaloids such as
aconitine which produce neurologic, cardiovascular, and gastrointestinal disturbances. Use of
these herbs can even result in death [Chan TYK, 1993].
41.2. Radix Salviae Miltiorrhizae and its components
Radix Salviae Miltiorrhizae (RSM), an important constituent of Chinese folk medicine, is the
root extract of the plant Salvia Miltorrhizae Bunge (Fig. 1), which belongs to the family of
Labiatae. Both injection solution and tablets made from RSM have been widely used in the
Chinese community for various complaints, particularly cardiovascular and cerebrovascular, such
as ischemia, myocardial infarction and thrombosis.
Fig. 1 The plant Salvia Miltiorrhizae Bunge and its dry root, which is being used as an important Chinese folk
medicine.
Several studies within the last few years showed that RSM exhibits cardioprotective effects [Wu
W, 1992; Zou ZW, 1993 and Kuang P, 1995]. Also the ability of RSM to suppress platelet
aggregation and anti-thrombotic effects may contribute to improve cardio- or cerebral-circulation
[Chen WZ, 1984; Li CZ, 1984 and Kuang PG, 1991]. Our unpublished data showed that RSM
reduced both ischemic brain injury and leukocyte infiltration following cerebral ischemia-
reperfusion, may be partially mediated via an ATP-sensitive potassium channel (KATP)-linked
mechanism. Seven phenolic compounds have been isolated from the water-soluble extract of
RSM by Li et al. [Li NL, 1984] (Fig. 2) and have been reported to employ multiple
5pharmacological activities [Liu GT, 1992]. The activities of scavenging oxygen free radical and
inhibiting lipid peroxidation among the compounds were extensively studied [Li DY, 1995].
These phenolic compounds have a strong protective action against oxygen free radical induced
peroxidative damage [Xi SC, 1994 and Zhang X,1994]. They are the active principle of RSM
responsible for antioxidant activity and at least a part of the pharmacological bases for using
RSM for the clinical treatment of certain diseases. Based on the protective effects, it has been
proposed that RSM and its components may prevent apoptosis in response to pathophysiological
signals. In the next paragraph, an overview about apoptosis will be provided.
Fig. 2 Chemical structures of water-soluble components isolated from Radix Salviae Miltiorrhizae.
61.3. Apoptosis
1.3.1. Introduction
Death of cells has aroused far less interest than other basic cellular processes such as proliferation
and differentiation. The relative neglect probably results at least in part from the wide prevalence
of an unjustifiably circumscribed and restricted notion of cell death as a degenerative
phenomenon produced by injury. This concept evolved early in the history of cellular pathology
[Virchow R, 1858] and has tended to dominate thinking about both the incidence and the
mechanisms of cell death ever since. In 1972 a new concept of cell death—apoptosis was firstly
proposed by Kerr et al [Kerr JF, 1972]. He described that apoptosis was an active, precisely
regulated, and energy requiring process that seemed to be orchestrated by a genetic program.
Herence the terms apoptosis and programmed cell death were interchangeable. Apoptosis can be
triggered by a variety extrinsic and intrinsic signals [Vaux DL, 1994]. This type of regulation
allows for the elimination of cells that have been produced in excess, that have developed
improperly, or that have sustained genetic damage.
1.3.2. The morphology of apoptosis
The morphology of cellular death is now distinguished into two types, apoptotic cell death and
necrotic cell death. Necrotic cell death is a pathologic form of cell death resulting from acute
cellular injury, which is typified by rapid cell swelling and lysis. In contrast, apoptotic cell death
is characterized by controlled autodigestion of the cells. Cells appear to initiate their own
apoptotic death through the activation of endogenous proteases. This results in cytoskeletal
disruption, cell shrinkage, and membrane blebbing. Electron microscopy shows that the structural
changes in apoptosis take place in two discrete stages (Fig. 3): the first comprises the formation
of apoptotic bodies, the second their phagocytosis and degradation by other cells. Apoptosis also
involves characteristic changes within the nucleus. The nucleus undergoes condensation as
endonucleases are activated and begin to degrade nuclear DNA. In many cell types, DNA is
degraded into DNA fragments the size of oligonucleosomes, whereas in others larger DNA
fragments are produced. Apoptosis is also characterized by a loss of mitochondrial function. The
dying cell maintains its  plasma membrane integrity. However, alterations in the plasma
7membrane of apoptotic cells signal neighboring phagocytic cells to engulf them and thus to
complete the degradation process. Cells not immediately phagocytosed break down into smaller
membrane-bound fragments called apoptotic bodies. An important feature of apoptosis is that it
results in the elimination of the dying cell without induction of an inflammatory response. In
contrast, necrotic cell death is associated with an early loss of  cell membrane integrity, resulting
in leakage of cytoplasmic contents and the induction of an inflammatory response [Wyllie AH,
1980].
Fig. 3 Diagram to illustrate the morphological features of apoptosis.
81.3.3. Significance of apoptosis in diseases
It is now widely accepted that apoptosis is of central importance for the development and
homeostasis of metazoan animals. For example, apoptosis serves as a prominent force in
sculpting the developing organism [Hammer SP, 1971], as a major mechanism for the precise
regulation of cell numbers [Raff MC, 1992 and 1993], and as a defense mechanism to remove
unwanted and potentially dangerous cells, such as self-reactive lymphocytes [Cohen JJ, 1991],
cells that have been infected by viruses [Vaux DL, 1994 and  Debbas M, 1993], and tumor cells
[Williams GT, 1991]. Not surprisingly, the initiation of apoptosis is carefully regulated. Many
different signals that may originate either from within or from outside a cell have been shown to
influence the decision between life and death. These include lineage information, cellular damage
inflicted by ionizing radiation or viral infection, extracellular survival factors, cell interactions,
and hormones [Raff MC, 1992 and 1993, and Steller H, 1994]. These diverse signals may act to
either suppress or promote the activation of the death program, and the same signal may actually
have opposing effects on different cell types [Truman JW, 1984]. Recent evidence suggests that
the failure of cells to undergo apoptotic cell death might be involved in the pathogenesis of a
variety of human diseases, including cancer, autoimmune diseases, and viral infections [Bursch
W, 1992]. In addition, the inappropriate activation of apoptosis may also cause or contribute to a
variety of diseases, including acquired immunodeficiency syndrome (AIDS) [Banda NK, 1992],
neurodegenerative diseases, and ischemic stroke [Raff MC, 1993 and Martinou JC, 1994 ] (Fig.
4).
Diseases Associated with Inhibition of Apoptosis
1. Cancer
Follicular lymphomas
Carcinomas with p53 mutations
Hormone-dependent tumors
Breast cancer
Prostate cancer
Ovarian cancer
2. Autoimmune disorders
Systemic lupus erythematosus
Immune-mediated glomerulonephritis
3. Viral infections
Herpesviruses
Poxviruses
Adenoviruses
9Diseases Associated with Increased Apoptosis
1. AIDS
2. Neurodegenerative disorders
Alzheimer’s disease
Parkinson’s disease
Amyotrophic lateral sclerosis
Retinitis pigmentosa
Cerebellar degeneration
3. Myelodysplastic syndromes
4. Ischemic injury
Myocardial infarction
Stroke
Reperfusion injury
5. Toxin-induced liver disease
Alcohol
Fig. 4. Diseases associated with the induction or inhibition of apoptotic cell death.
1.3.4. Regulation of cell death: therapeutic potential
The realization that apoptosis represents an active, gene-directed mechanism has fostered
optimism that it may be possible to control apoptosis with the development of drugs that act
against the molecular components of the death machinery. Specific therapies designed to enhance
or decrease the susceptibility of individual cell types to undergo apoptosis could form the basis
for treatment of a variety of human diseases.
1.4. Flow channel technique
A computer controlled flow channel system (Elias-c-) based on photometric light transmission
measurements through cell monolayers was employed to investigate antioxidative capacities of
natural herbal drugs and compounds [Artmann GM, 1995 and 1996]. Reactive oxygen species
such as hydrogen peroxide (H2O2) are highly reactive molecules produced during the course of
normal cellular processes involving oxygen. Oxidants have the potential to create situations of
oxidative stress within cells by reacting with macromolecules causing damage to cellular
structures and functions [de Haan J, 1998]. Nature has established highly effective antioxidative
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defense mechanisms within cells themselves and within the lipid phase of the cell membrane
[Ursini F, 1985]. In addition to these, drugs and natural healing substances, in some cases
prescribed for completely different indications, act as highly effective antioxidative agents. A
flow channel technique was designed to investigate antioxidative capacities of natural herbal
drugs and compounds. In an automated form of flow channel system (analyzer Elias-c-), the
analyzer is highly accurate and sensitive to evaluate RBC-stiffness and -relaxation time as well as
RBC-EC adhesion. When RBC prepared as monolayers on a coverslip were treated with
hydrogen peroxide, the stiffness enhanced time-dependently whereas the relaxation time declined
[Schrier SL, 1992 and Artmann GM 1993]. Also hydrogen peroxide alters the physical state and
function of the plasma membrane of endothelial cells and facilitates RBC adhesion [Block ER,
1991]. Antioxidants as shown in this study counteract these effects. In contrast to other
biochemical or physical techniques to study the antioxidative capacity of drugs [Stern A, 1985
and Pincemail J, 1989], this method enables investigations on living cellular structures, i.e.,
above the molecular and below the animal experiment level.
Two herbs were chosen in the present study. (1) Tetramethylpyrazine (ligustrazine, TMP) is a
mono-molecular metabolically active constituent of a Chinese herb Ligusticum wallichii
Franchat. TMP is available commercially in China for treatment of a variety of vascular diseases,
notable ischaemic stroke disease [Chen KJ, 1992], and pulmonary hypertension secondary to
chronic obstructive pulmonary disease (COPD) [Peng W, 1991 and Liu SM, 1994]. TMP is
known to act as an antioxidant by scavenging free radicals [Zhang ZH, 1994]. The therapeutic
effects of TMP are likely to be via its action as a vasodilator [Sutter MC, 1993], inhibition of
platelet aggregation [Liu SY, 1994], protection of endothelial cells against low density
lipoprotein-induced damage [Li YJ, 1994]. (2) Dhpl (3,4-dihydroxyphenyl lactate), as one
component of RSM was used in RBC-EC adhesion studies. Since RBC and EC could be the
direct damaging targets of oxygen free radical in blood flow, and red blood cell aggregability,
deformability and adherence to endothelial cells play a major role in hemodynamics, particularly
in small blood vessels, as well as their impairment has been linked to microcirculatory disorders
in numerous pathological states [Hovav T, 1999]. Thus RBC and EC were chosen as in vitro
model systems for the flow channel assay. The efficacy of Dhpl to inhibit hydrogen peroxide
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induced damage leading to RBC-EC adhesion was compared with Vitamin E, a well-known
antioxidant.
1.5. Aim and importance of this study
In this thesis, the activities of two components of RSM, PAC and PAL, in cell protection from
apoptosis were investigated. RSM is being used in traditional Chinese medicine as a treatment for
cardiovascular and cerebrovascular diseases. Recent studies have indicated that RSM exhibited
cardio- or cerebro-protective effects. However, how exactly RSM and its components exert their
protective actions and the molecular basis of those effects are not well known yet. Based on the
protective effects, it has been proposed that RSM and its components may prevent programmed
cell death in response to pathophysiological signals. Therefore, the study was to analyze the
effect of PAC and PAL on apoptosis, and to elucidate the molecular basis of their anti-apoptotic
effect. In addition, a computer controlled flow channel system was employed to examine
antioxidative capacity of TMP and Dhpl.
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2. Materials and Methods
2.1. Buffers and Solutions
2.1.1. Routine buffers and solutions
All buffers and solutions were prepared under sterile condition by filters or autoclave.
PBS (10x) 40 g NaCl pH 7.4
1 g KCl
5.8 g Na2HPO4
1 g KH2PO4 in 500ml d H2O
PBS 50 ml 10x PBS in 500ml d H2O
HEPES buffer (10x) 40 g NaCl pH 7.55
1.5 g KCl
11.9 g HEPES
10 g Glucose in 500ml d H2O
HEPES buffer 55.6 ml 10x HEPES buffer in 500ml d H2O
HEPES transport buffer 55.6 ml 10x HEPES buffer in 500ml d H2O
4 ml Fungizone
4 ml penicillin-streptomycin solution
2.1.2. Cell Culture
Collagenase I (0.2%) 0.2 g Collagenase I pH 7.55
Store in –20°C in 100 ml 1x HEPES buffer
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EDTA (0.02%) 0.02 g EDTA pH 7.55
1.5 ml BSA (35%) in 100 ml PBS
Gelatin (0.2%) 0.2 g Gelatin in 100 ml PBS
2.1.3. Transformation
Ampicillin solution 50 mg ampicillin-Na-salt per ml H2O
Sterile filtration, store in –20°C
LB-medium 10 g Bactotrypton
5 g Bacto-Yeast Extract
10 g NaCl in 1 L d H2O
(for LB-plates: 15g Agar per Liter)
Mini prep Solution I 50 mM glucose
25 mM Tris·Cl (pH 8.0)
10 mM EDTA (pH 8.0)
Mini prep Solution II 10 µl 10N NaOH
440 µl d H2O
50 µl 10% SDS
Mini prep Solution III 5 M potassium acetate 60 ml
Glacial acetic acid 11.5 ml
H2O 28.5 ml
2.1.4. Western Blotting
Nonfat milk buffer (10%) 10 g milk powder in 100 ml PBS
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Antibody I (1:1000) 10 µl IκB-alpha in 10 ml 10% milk buffer
Antibody II (1:300) 40 µl anti-rabbit-AP-IgG  in 12 ml d H2O
2.1.5. EMSA
Nucleuprep lysis buffer I 500 µl 1M HEPES-NaOH (pH 7.9)
500 µl 1M KCl
100 µl 0.5M EDTA (pH 8.0)
5 µl 0.1M EGTA in 50 ml d H2O
Nucleuprep lysis buffer II 1 ml 1M HEPES-NaOH (pH 7.9)
4 ml 5M NaCl
10 µl 0.5M EDTA (pH 8.0)
500 µl 0.1M EGTA in 50 ml d H2O
TBE (10x) 54 g Tris
27.5 g Borsäure
40 ml 0.5M EDTA (pH 8.0) in 500 ml d H2O
5xEMSA binding buffer 25 mM HEPES pH 7.8
25 mM MgCl2
250 mM KCl
1 mM EDTA
25 mM DTT
50 % glycerin
Loading buffer 80% Formamid
10 mM NaOH
16
1 mM EDTA
0.1% Xylene cyanol blue
0.1% Bromphenolblau
Gel buffer 12 ml 30% PAA
1.5 ml 10x TBE
add 70 ml d H2O
75 µl TEMED
300 µl APS
Running buffer 12.5 ml 10x TBE in 500 ml d H2O
2.1.6. Flow Channel Assay
HEPES+ buffer 0.5 g glucose in 500 ml HEPES buffer
HEPES++ buffer 0.5 g bovine albumin in 500 ml HEPES+ buffer
100µM H2O2 11.4 µl 30% H2O2 in 10ml DMEM
degas for 5 min, then 1:100 dilute
in DMEM
2.2. Chemicals
Plasmids NF-κB Cis-reporter plasmid (Stratagene, Amsterdam,
Netherland) was used in luciferase assay to analyse NF-κB
transcriptional activity. As a control for transfection efficiency
pRL-TK plasmid (Promega, Mannheim) was together used with
NF-κB plasmid.
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Amersham, Braunschweig PolydIdC
Bio Rad, München PVDF membrane
Boehringer Mannheim RIPA buffer set
Chemicon, Hofheim/Ts Sheep anti-rabbit IgG-alkaline phosphatase secondary antibody
Falcon, Heidelberg Cell culture articles, ELISA-plates
Kodak, Rochester (USA) X-Omat imaging film
Macherey-Nagel, Dueren Nucleobond AX Kit for maxi-prep
Merck, Darmstadt APS, Borsäure, EDTA, EGTA
Novex, Frankfurt am Main Bluemarker, running buffer and transfer buffer for western blot
PAA, Martinsried Penicillin-Streptomycin-L-glutamin solution, culture medium
Pierce, Bonn BCA protein assay kit
Promega, Mannheim Dual-Luciferase reporter assay kit
NF-κB Oligonucleotide (5’-AGTTGAGGGGACTTTCCCAGG-
3’)
Roche, Mannheim Cell proliferation kit II (XTT), 10% NP-40, protease-inhibitor-
cocktail tablet
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Santa Cruz, Ismaning IkBα antibody (C-21), NF-κB p50 antibody (C-19), NF-κB p65
antibody (C-20)
Serva, Heidelberg EDTA, Nonfat milk powder, Bovine albumin
Sigma, Deisenhofen Fetal calf serum, Dulbecco’s PBS, TNF-α, ActD, MG 132,
protocatechuic acid, protocatechuic aldehyde, BCIP/NBT, 30%
PAA, TEMED, Vitamin E, 30% H2O2
Upstate, Lake Placid, USA NF-κB inhibitory ligand
2.3. Methods
2.3.1. Cell culture
Jurkat cells (ATCC TIB-152) were maintained in RPMI 1640 supplemented with penicillin (400
U/ml), streptomycin (50 µg/ml), L-glutamine (300 µg/ml) and 10% fetal calf serum (FCS) and
splitted 1:10 every three days.
Human umbilical cord vein endothelial cells (HUVEC) derived from umbilical cord were isolated
as described previously [Jaffe EA, 1973]. In brief, the vein was washed with 20 ml HEPES buffer
to remove the blood. After washing, the vein was incubated for 15 min at 37°C in an incubator
after injecting 10 ml of collagenase solution (1 mg/ml). The vein was then rolled gently and the
collagenase solution containing the cells was washed off with 20 ml Ham’s F-12/IMDM medium
(without serum). The complete 30 ml of cell suspension was centrifuged at 1100 U/min for 10
min without break. The pellet was resuspended and cultivated in a gelatin-coated flask with 4 ml
Ham’s F-12/IMDM medium supplemented with 40,000 units penicillin/streptomycin/L-
glutamine solution and 20% human serum under a humidified atmosphere of 5% CO2 at 37°C.
Cells were detached for subcultivation or assay with 0.2% collagenase, 0.02% EDTA in HEPES-
buffer and only used for experiments at passages 2 to 4.
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Bovine aortic endothelial cells (BAEC) were isolated from aortas of freshly slaughtered cow
[Zink S, 1995]. The lumen of the aortas was washed with PBS under sterile conditions and the
adventitia was removed. The remaining part was immersed completely in 30 ml of dispase
solution (0.5 mg/ml) for 15 min at 37°C. Afterwards the aortas were put on an aluminum tray and
the BAEC were scraped off. The cells were then plated in a gelatin coated 6-well dish. BAEC
were cultivated in 5% CO2 in Dulbecco’s modified Eagle’s medium (Sigma Chemical Co,
Aldrich, Germany) supplemented with 10% fetal calf serum. Subcultures were harvested with
trypsin and splitted at a 1:3 ratio into cell culture flasks. Cells at passage 3-12 were used for
experiments.
2.3.2. Cell stimulation
In the experiments, different stimulators were applied on cells. Their concentration were
respectively:
TNF-α 10 ng/ml
ActD 1 µg/ml
MG132 5 µg/ml
NF-κB inhibitory peptide 50 µg/ml
PAC 100 µM, 1 mM (for XTT HUVEC)
50 µM, 100 µM, 500 µM, 1 mM (for XTT Jurkat)
100 µM (for other experiments except XTT)
PAL Same as PAC
TMP 88.5 µM
Dhpl 50 µM
Vitamin E 50 µM
H2O2 2 mM and 100 µM
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2.3.3. Cell viability Assay (XTT Assay)
For viability assays, cells were seeded into 96-well plates at a density of 7500 cells/well in 2%
serum medium. By the following day, cells had reached 80% confluence and were washed with
serum-free medium. Various concentrations of PAC / PAL as indicated were applied to the cells
either 2 hours before TNF-α treatment (10ng/ml) or simultaneously. PAC/PAL was either left on
the cells during TNF-α treatment or washed away before. For MG132 treatment, MG132 (5
µg/ml) was applied 30 min before PAC/PAL addition. After cell treatment, 50µl of the XTT
labeling mixture (final XTT concentration 0.3mg/ml), prepared as manufacturer’s description,
was added to each well. The microtiter plate was incubated for 4 h in a humidified atmosphere.
The spectrophotometrical absorbance of the samples was measured using a ELISA reader. The
wavelength to measure absorbance of the formazan product was between 450 and 500 nm.
2.3.4. Morphology
NF-κB inhibitory peptide is a cell-permeable peptide which carries a functional cargo
representing the nuclear localization sequence of NF-κB p50. It can be applied to inhibit nuclear
translocation of NF-κB  in a concentration-dependent manner [Lin YZ, 1995]. 45,000 Huvec
cells per slide were plated onto 4-well slide coated with 0.2% gelatin and allowed to attach
overnight. At the following day, the nearly confluent cells were pre-incubated with PAC (100
µM) for 2 hours and then exposed in TNF-α (10 ng/ml) in the presence of ActD (1 µg/ml) for
another 2 hours. NF-κB inhibitory peptide (50 µg/ml) was added to the cells 15 min prior to PAC
stimulation. Morphology of the cells was analyzed under contrast microscope.
2.3.5. Transformation
Bacterial transformation is the process by which bacterial cells take up naked DNA molecules or
plasmid DNA. If the foreign DNA has an origin of replication recognized by the host cell DNA
polymerases, the bacteria will replicate the foreign DNA along with their own DNA. When
transformation is coupled with antibiotic selection techniques, bacteria can be induced to uptake
certain DNA molecules, and those bacteria can be selected for that incorporation. Bacteria which
21
are able to uptake DNA are called "competent" and are made so by treatment with calcium
chloride in the early log phase of growth. The bacterial cell membrane is permeable to chloride
ions, but is non-permeable to calcium ions. As the chloride ions enter the cell, water molecules
accompany the charged particle. This influx of water causes the cells to swell and is necessary for
the uptake of DNA. The exact mechanism of this uptake is unknown. It is known, however, that
the calcium chloride treatment can be followed by heat. When E. coli are subjected to 42°C heat,
a set of genes are expressed which aid the bacteria in surviving at such temperatures. This set of
genes are called the heat shock genes. The heat shock step is necessary for the uptake of DNA.
100 µl competent bacteria were combined with 0.3 ~1 µl plasmid (NF-κB -luc plasmid: 1.56
µg/µl, pRL-TK plasmid: 1.99 µg/µl) and first incubated for 30 min on ice and then incubated at
42°C for 90 seconds. After the heat shock step, the mixture was resuspended in 1 ml LB and
incubated at 37°C for 30~60 min in a shaking incubator. The transformed mixture was
centrifuged at 3000 U/min for 5 min. The appropriate volume of the pellet suspension was
spreaded gently over the surface of LB- ampicillin –agar plate and incubated over night.
2.3.6. Mini-Prep
For the isolation of plasmid-DNA the standard alkaline lysis purification method was used
[Sambrook J, 1989]. The standard method for the miniprep isolation of plasmid DNA includes
the same general strategy as the large scale isolation. Generally, smaller aliquots of antibiotic
containing liquid media inoculated with plasmid-containing cell colonies are incubated in a 37°C
shaker for 12-16 hours. After collecting the plasmid containing cells by centrifugation, the cell
pellet is resuspended in a hypotonic sucrose buffer. The cells are successively incubated with an
RNAase-lysis buffer, alkaline detergent, and sodium acetate. The lysate is cleared of precipitated
proteins and membranes by centrifugation, and the plasmid DNA is recovered from the
supernatant by isopropanol precipitation.
To perform mini-prep, a single Bacterial colony was transferred into 5 ml LB-ampicillin medium
in a loosely capped 15 ml tube and incubated overnight at 37°C with vigorous shaking. 1.5 ml of
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the culture was centrifuged at 12000 g for 5 min. The bacterial pellet was resuspended in 100 µl
ice-cold Solution I and incubated no longer than 5 min on ice. 200 µl of freshly prepared Solution
II was added by inverting the tube rapidly 5 times. 150 ml Solution III was immediately added
and the tube was vortexed for 10 seconds, and then stored on ice for 3~5 min. The contents were
centrifuged and the proteins in the supernatant was extracted with an equal volume of
phenol:chloroform (1:1). 900 µl ethanol was used to precipitate the plasmid DNA. The dry DNA
pellet was dissolved in 10 µl H2O with RNAase (100 µg/ml).
2.3.7. Maxi-Prep
Large-scale preparations of plasmid DNA was preformed by using Maxi-Prep-Kit from
Macherey-Nagel (Dueren). The procedure was following the manufacturer’s description. The
concentration of the plasmid DNA was determinated by measuring its OD260 value.
2.3.8. Gel electrophoresis to analyze plasmid DNA
To analyze the DNA by cleavage  with restriction enzymes, 1 µl of the DNA solution was
removed from Mini /Maxi-prep and added to a fresh microfuge tube containing 1 unit of the
desired restriction enzyme, 1µl of the 10x restriction enzyme buffer and water. The total volume
was 10 µl in the microfuge. The reaction was incubated for 1 h at 37°C, and then loaded in a
0.8% Agarose gel. Electrophoresis was carried out at 120 V for 45 min. At the end of the run, the
gel was removed from the tank and soaked in ethidium bromide solution for 20 min staining and
then analyzed.
2.3.9. Transient transfection
2x 106 cells were transiently transfected with 5µg NF-κB -luc plasmid using the electroporation
method according to the manufacturer’s instructions. Briefly, the cells were harvested and
centrifuged at 300g x 10 min. The cell pellet was resuspended in 100 µl PBS to a concentration
of 2x 107 and kept on ice. Each 2x 106 cells were combined with 5 µg NF-κB -luc plasmid and
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0.2 µg pRL-TK as a control for transfection efficiency in 100 µl solution B, then the sample was
transferred immediately into a 2 mm cuvette. The cuvette was inserted into the cuvette holder and
program 3A was applied. After transfection, the cuvette was immediately rinsed with 400 µl
complete medium. Then 2x 106 transfected cells were divided into 2 wells of a 6-well plate. After
transfection the cells were cultivated for 24 hours and then 100 µM PAC was applied for various
periods of time. The cells were harvested by incubation in passive lysis buffer. Firefly and
Renilla luciferase activities were determined using the DualLuc substrates.
2.3.10. Preparation of whole cell lysates
4x105 Huvec or 1x106 cells grown in T-25 flasks were treated with reagents for the times
indicated, washed twice with ice-cold PBS, and harvested in 100µl RIPA cell lysis buffer
containing 50mM Tris-HCl, 150mM NaCl, 1% Nonidet P40, 0.5% Natriumdesoxycholat, 0.1%
SDS and protease-inhibitor-cocktail tablet. The cells were incubated for 15 min on ice and then
centrifuged at 15,000 g for 10 min. The supernatant was recovered. Protein concentration was
determinated by using BCA protein assay kit.
2.3.11. Western blotting
8 µg per each lane of RIPA-cell lysate was separated on a 4-12% SDS-PAGE gradient gels and
subsequently blotted onto a PVDF membrane. After blocking for 1 hour with 10% nonfat dry
milk/ PBS, the membrane was incubated for 16 hours with the specific antibody against IkB-α
(1:1000). Then the membrane was washed three times in PBS, incubated for 1 hour with an
alkaline phosphatase-coupled secondary antibody (anti-rabbit) and then washed again. For
detection NBT / BCIP staining was used.
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2.3.12. EMSA
2.3.12.1. Preparation of nuclear lysates
To analyze nuclear DNA-binding proteins such as transcription factors, nuclear protein need to
be isolated from the cells. After cell stimulation, the cells were collected by scraping from T-75
flasks and washed 2 times with PBS. The cells were then added with 400 µl Lysis buffer I and
incubated for 15 min on ice. 25 µl 10% NP-40 were added to the cells and mixed by short
vigorous shaking. The cells were then centrifuged (10000 U/min, 2 min) and the pellet was
resuspended with 50µl lysis buffer II and incubated with shaking for 15 min at 4°C. Finally the
contents were centrifuged at 4°C 13000 U/min for 10 min and the supernatant containing nuclear
protein (1-2 µg/µl) was aliquoted. Nuclear extracts were either used immediately or stored at –
70°C. The protein content of the extract was measured by using BCA protein assay kit.
2.3.12.2. EMSA
DNA-binding proteins can be measured quantitatively with the electrophoretic mobility shift
assay (EMSA), which also is referred to as the gel-shift or band-shift assay. In this assay, the
electrophoretic mobility of a radiolabeled DNA fragment is determined in the presence and
absence of a sequence-specific DNA-binding protein. Protein binding generally reduces the
mobility of a DNA fragment, causing a shift in the location of the fragment band detected by
autoradiography.
Gel shifts were performed as described previously [Bosserhoff AK, 1996]. 1 ng (10000cpm) 32P-
end-labeled double –stranded NF-κB oligonucleotide was incubated with 4-6 µg nuclear extract,
1 µl ploy-dIdC and 4 µl 5xEMSA buffer in room temperature for 10 min. Samples were loaded in
a 6% native PAA gel. Competition experiments were performed using 50 fold excess of the
unlabeled binding site, for supershifting experiments anti-p50 and anti-p65 antibodies were used.
The gel was dried by Whatman-paper and autoradiographed over night.
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2.3.13. Flow Channel Assay
2.3.13.1. Chinese medicine compounds
Tetramethylpyrazine (ligustrazine, TMP) is the active constituent of the Chinese herb Ligusticum
wallichii Franchat. TMP used in this study was available as injection ligustrazini hydrochloride
(20 mg/ml, sterile injection, M: 226 g/mol, Fourth Pharmaceutical Co., Beijing, China). TMP (20
mg/l equals 88.5 µM) was dissolved in HEPES buffer and it did not affect the osmolarity of the
buffer.
Dhpl (3,4-dihydroxyphenyl lactate, M: 197.17 g/mol) is a water-soluble component of RSM.
Dhpl was synthesized by Shanghai Medical University, Dept. of Pharmacology and purchased as
sterile injection (10 mg/ml). The purity was higher than 95% as quantitated by spectrum analysis.
To study its effect on RBC-EC adhesion, a concentration of 50 µM Dhpl was chosen.
2.3.13.2. Antioxidative capacity of Tetramethylpyrazine to RBC
Blood and RBC monolayer preparation
About 100 µl of blood was withdrawn from the finger tips or ear lobe of young healthy donors
with heparinized micropipettes and dispersed in 10 ml of HEPES. RBC were harvested after
centrifugation at 3500 rpm for 10 min. The RBC sediment was withdrawn and washed for three
times with HEPES. A 20 µl aliquot was re-suspended in 50 µl HEPES. 20 µl of this final RBC
suspension were pipetted onto the bottom of the flow chamber and allowed to settle for 10
minutes. After flushing away non-adhered RBC with HEPES+, the RBC monolayer preparation
was ready for use.
Apparatus
The automated Elias-c-analyzer (Fig. 5) consists of a microscope, a computer-controlled pump, a
flow chamber and a microprocessor unit. The stainless steel flow chamber forms a flow channel
with a rectangular cross-section (width, 14mm; length, 55 mm). The assembly of the chamber
forms a flow channel with a height of 0.228 ± 0.009 mm. A pulsatile reduced suction pump is
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controlled by computer and produced a stationary maximum wall shear stress of 3 Pa. For
relaxation time measurements, flow stoppage is accomplished within 10ms by closure of a micro-
valve [Artmann GM, 1995 and 1996].
Fig. 5 Original photograph of the automated Elias-c-analyzer based on the Microscopic Photometric Monolayer
Technique.
RBC stiffness and relaxation time measurements
RBC stiffness (in Pa) is defined as the ratio of 0.25 Pa wall shear stress to RBC elongation at
0.25 Pa. The relaxation time (in ms) is calculated from the dynamic shape recovery curves after
flow stoppage. The relaxation time is taken when the photometrical signal has declined to 50% of
the previous RBC elongation at 2.0 Pa shear stress [Artmann GM, 1995].
Time sequence and experimental conditions
RBC stiffness and relaxation time were recorded subsequently with the same RBC mono- layer
for each donor. The total investigation time per monolayer was 72 min. Exposure times and
sequences of exposure to H2O2 and TMP, respectively, are given in Fig. 6.
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total time 2’ 22’ 42’ 72’
time per step 2 min 20 min 20 min 30 min
controls HEPES++ HEPES++ HEPES++ HEPES++
H2O2 (2 mM) HEPES++ H2O2 HEPES++ HEPES++
TMP
(88.5µM)
HEPES++ H2O2 TMP TMP
Fig.6 Time protocol and steps of exposure to hydrogen peroxide and TMP, respectively.
2.3.13.3 Effects of Dhpl and Vitamin E on RBC-EC adhesion
Dhpl and Vitamin E preparation and EC treatments
Hydrogen peroxide (H2O2, 30%) and +-α-Tocopherol acetate (Vitamin E) were purchased from
Sigma. Vitamin E was first dissolved in 98% ethanol as stock solution, with a final ethanol
concentration of 0.1% in culture medium. Vitamin E and Dhpl were freshly prepared at 50 µM in
cell culture medium prior to use.
Pre-treatment studies: EC were first incubated with 50 µM Dhpl or 50 µM Vitamin E,
respectively, for 1 h at 37°C at 5% CO2 and then activated by 100 µM H2O2 for 30 min.
Post-treatment studies: EC were first activated with 100 µM H2O2 for 30 min and then incubated
with 50 µM Dhpl or 50 µM Vitamin E, respectively, for 1h.
Before adhesion studies were carried out, the EC were gently rinsed for three times with DMEM
without FCS.
RBC preparation and treatment
Blood samples were withdrawn from the fingertip of healthy human donors. The RBC were
centrifuged, washed 3 times with DMEM and resuspended in DMEM (30% hematocrit). Before
the adhesion test, the RBC were treated with 100 µM H2O2 for 30min.
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Evaluation of RBC – EC adhesion
The EC which were cultured on microslides, were placed into a flow chamber. 20 µl of H2O2
treated RBC suspension was pipetted on top of the EC monolayer covering the EC layer. RBC
were allowed to settle at no flow for 15 min onto the EC within the closed flow chamber.
Subsequently, a wall shear stress of 0.04 Pa was applied for 5 min to wash away non-adherent
RBC. The remaining RBC were counted in random fields of the EC monolayer. RBC-EC
adhesion was tested at three different modes of exposure to H2O2:
1) only RBC were treated  2) only EC were treated  3) both EC and RBC were treated.
3. Results
3.1. Analysis of PAC on TNF-α induced apoptosis
Acute or chronic ischemia resulting from cardio- and cerebrovascular diseases leads to apoptotic
cell death. Since anti-apoptotic therapies have been proposed to limit tissue damage, we have
therefore investigated whether PAC, a component of the Chinese Herb RSM, could potentially
protect cells from apoptosis.
3.1.1. PAC blocks TNF-α induced cytotoxicity
TNF-α is one of the most potent inducers of apoptosis [Rath PC, 1999]. Whether PAC modulates
TNF-α induced apoptosis is investigated. In the presence of ActD (1 µg/ml), TNF-α (10 ng/ml,
16 hours) profoundly sensitized Huvec cells to apoptosis, whereas 2 hours pretreatment with
PAC partially protected the cells from death (Fig. 7).
Fig. 7 Morphological analysis of the effect of PAC on TNF-α induced apoptosis in Huvec and Jurkat cells.
Pretreatment of Huvec cells with PAC increased resistance to cell death caused by subsequent treatment
with TNF-α (10 ng/ml) in the presence of actinomycin D (1 µg/ml). (a) normal Huvec cells after 16 hours of
incubation in culture medium (magnification, ×170). (b) confluent cells were treated with TNF-α for 16
hours in the presence of actinomycin D. (c) confluent cells were pretreated with 1 mM PAC for 2 hours
followed by TNF-α for 16 hours in the presence of actinomycin D.
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To quantify the number of cells undergoing apoptosis, the XTT dye reduction assay was
performed (Fig. 8).
Fig. 8 Dose-dependent protection of Huvec cells (1) and Jurkat cells (2) from apoptosis was measured using XTT
assays to analyze viability of the cells. PAC was applied to the cells 2 hours before TNF-α treatment (10
ng/ml) and either left on the cells during TNF-α treatment or washed away before or treated with PAC
simultaneously with the TNF-α treatment. As a control non treated cells and cells treated with TNF-α alone
were used. In the case of Huvec cells apoptosis was always induced by adding TNF-α together with
actinomycin D (1 µg/ml). Data indicated the means of 6 and 4 individual experiments in Huvec and Jurkat
cells, respectively, and each experiment was done in triplicate (+ vs. Control, * vs. TNF-α).
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16 hours incubation of Huvec and Jurkat cells with TNF-α (10 ng/ml) resulted in 55% and 37%
cell death, respectively. PAC was shown to inhibit TNF-α induced apoptosis in both cell types.
The protection was seen when PAC was added 2 hours before or simultaneously with the TNF-α
but not when PAC was washed from the cells after two hours before TNF-α treatment. Further,
the effect on Jurkat cells was dose-dependent. Maximal protection by treatment with 1 mM PAC
resulted in 44% more living cells in Huvec and 380% in Jurkat than TNF-α treated cells.
3.1.2. PAC activates DNA-binding ability of NF-κB proteins
Resistance to TNF-α cytotoxicity can be achieved through different signaling pathways [Guo
YL, 1999]. Recently an activated form of NF-κB has been proposed to switch on transcription of
yet unidentified anti-apoptotic genes and therefore in development of resistance to TNF-α [Natoli
G, 19981]. To analyze the molecular mechanism of PAC protection from apoptosis induced by
TNF-α, activation of NF-κB was analyzed. The nuclear extracts from 100 µM PAC-treated
Huvec and Jurkat cells were examined for DNA-binding ability by EMSA. The results revealed
PAC to activate DNA-binding of NF-κB proteins (Fig. 9).
Fig. 9 EMSA analyzed DNA binding of NF-κB after PAC treatment. Huvec (A) and Jurkat cells (B) were treated
with PAC (100 µM) for the indicated times. Then nuclear proteins were extracted and assayed versus a non
PAC treated control.The amount of active NF-κB in the nucleus of the cells was assayed by binding to an
oligonucleotide harboring the conserved NF-κB binding motif.
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Maximal activation of NF-κB bandshift activity was seen within 30 min in both cell types.
Supershift assays using antibodies to either the p50 or p65 subunits of NF-κB verified the
specificity of the shifting NF-κB complex in both Huvec and Jurkat cells (Fig. 10).
A: B:
Fig.10 Supershift assay verified the specificity of the shifting NF-κB complex in both Huvec and Jurkat cells.
3.1.3. Activation of NF-κB controlled reporter gene by PAC
3.1.3.1 Purification of NF-κB luciferase reporter gene by Mini and Maxi prep
NF-κB luciferase reporter gene construct belongs to a cis-reporting system, which is designed for
rapid assessment of the in vivo activation of many intracellular transduction pathways. Each cis-
reporter plasmid contains the luciferase reporter gene driven by a basic promoter element (TATA
box) joined to the tandem repeats of AP-1, CRE, SRE, NF-κB, p53 or SRF binding elements.
Increased luciferase expression indicates either direct or indirect transcripitional activation (Fig.
11).
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Fig.11 Diagram of cis-reporter backbone.
NF-κB cis-reporter plasmid was digested by XbaI after purification by Mini/ Maxi-prep. 2 bands
(about 1.4 kb and 4 kb) appeared on 0.8% agarose gel. pRL-TK plasmid as a control of
transfection efficiency was digested by Bgl II/ Hind III. 2 bands (760 bp and 3285 bp) appeared
on 0.8% agarose gel (Fig. 12).
Fig. 12 Digestion of NF-κB cis-reporter plasmid on 0.8% agarose gel.4 kb
  1.4 kb3285bp760bpNF-κBpRL-TK
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3.1.3.2. Effects of PAC on activation of NF-κB controlled reporter gene
NF-κB activation could be determined in luciferase assays using a trimerized NF-κB site
controlling a luciferase reporter (Fig. 13).
Fig. 13 Activation of NF-κB after PAC treatment was analyzed by luciferase assay. Cells (A: Huvec B: Jurkat cells)
were transfected with 5µg NF-κB -luc plasmid using electroporation. As a control for transfection efficiency
pRL-TK was used. 24 h after transfection, the cells were subsequently treated with PAC (100µM) for 30
min, 1 hour, 2 hours and 4 hours. Non PAC treated cells were used as control. Results show the means of
duplicate in a single experiment and represent three separate experiments.
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Cells were transiently transfected with a NF-κB dependent reporter, and the activity of NF-κB
was then measured after PAC treatment. The results showed that the activity of NF-κB was
significantly enhanced within 30 min of PAC stimulation.
3.1.4. Inhibitor of proteasome function suppresses the protective effect of PAC
The importance of NF-κB activation for PAC protection from apoptosis was further analysed by
the use of MG132, a proteasome inhibitor. MG132 inhibits NF-κB activation by preventing
degradation of IkB, the endogeneous inhibitor of NF-κB. Addition of MG132 in the experiments
led to loss of PAC protection from apoptosis (Fig. 14A and 14B).
Fig. 14A Inhibition of NF-κB activation by MG132 suppressed PAC function in Huvec cells. The protective effect
of PAC on TNF-α induced apoptosis was analyzed in the presence of MG132 (5 µg/ml). In XTT assays
cell viability was measured after adding MG132 to the cells 30 min before PAC treatment. Viability was
expressed as percentage of untreated cells. Data show the means of triplicate in a single experiment and
represent 6 individual experiments (+: vs. Control, *: vs.TNF, $: vs. 2h pretreat+16h TNF).
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Fig. 14B Inhibition of NF-κB activation by MG132 suppressed PAC function in Jurkat cells. The protective effect
of PAC on TNF-α induced apoptosis was analyzed in the presence of MG132 (5 µg/ml). In XTT assays
cell viability was measured after adding MG132 to the cells 30 min before PAC treatment. Viability was
expressed as percentage of untreated cells. Data show the means of triplicate in a single experiment and
represent 4 individual experiments (+: vs. Control, *: vs.TNF, $: vs. 2h pretreat+16h TNF).
3.1.5. Inhibition of NF-κB activation by NF-κB inhibitory peptide blocks PAC
function
NF-κB inhibitory peptide, a cell-permeable peptide bearing a functional domain of NF-κB p50
(Fig. 15), was reported to inhibite nuclear translocation of NF-κB in cultured endothelial cells
stimulated with different agonists [Li YZ ,1995]. Therefore, we examined whether activation of
NF-κB by PAC could be blocked by NF-κB inhibitory peptide.
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Fig.15 Sequence of NF-κB inhibitory peptide (single-letter amino acid code). The nuclear localization sequence of
NF-κB p50 is printed in bold face.
The results indicated that NF-κB inhibitory peptide inhibited PAC protection from TNF-α
induced apoptosis (Fig. 16). Taken together these results provided clear evidence that TNF-α
induced apoptosis was not suppressed by PAC when NF-κB activation was inhibited.
Fig. 16 Inhibition of NF-κB activation by NF-κB inhibitory peptide suppressed the anti-apoptotic effect of PAC.
Nearly confluent Huvec cells were pre-treated with PAC (100µM) for 2 hours and then exposed to TNF-α
(10 ng/ml) in the presence of actinomycin D (1 µg/ml) for 2 hours. NF-κB inhibitory peptide (50 µg/ml)
was added to the cells 15 min prior to PAC stimulation. Morphology of the cells was analyzed under
contrast microscope. (A): non treated Huvec. (B): Huvec cells were treated with TNF-α (10ng/ml) in the
presence of actinomycin D (1 µg/ml) for 2 hours. (C): Huvec cells were pre-treated with PAC (100µM) for
2 hours and subsequently exposed to TNF-α (10 ng/ml) in the presence of actinomycin D (1 µg/ml) for 2
hours. (D): NF-κB inhibitory peptide (50 µg/ml) was added to the Huvec cells 15 min prior to PAC
stimulation, and then the cells were treated as indicated for C.
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3.1.6. PAC activates NF-κB through degradation of IkBα
Next we aimed to analyze the molecular pathway of NF-κB activation by PAC. Translocation of
NF-κB into the nucleus is proceeded by phosphorylation and then ubiquitination-dependent
degradation of IkB. To determine whether the protective action of PAC was due to an effect on
IkBα degradation, Huvec and Jurkat cells were treated with 100 µM PAC for the times indicated
and then subjected to immunoblotting. A 37 kD protein (Fig. 17) was readily detected in
cytoplasmic extracts from unstimulated cells with peptide anti-serum raised against the carboxyl
terminus of IkBα.
IκBα (37KD)
1-72
73-242
243-317
Amino-terminal Central region consisting
of 5 ankyrin domains
Carboxyl-terminal
Origin single-letter amino acid code of IκBα
1 mfqaaerpqe wamegprdgl kkerllddrh dsgldsmkde eyeqmvkelq eirlepqevp
61 rgsepwkqql tedgdsflhl aiiheekalt mevirqvkgd laflnfqnnl qqtplhlavi
121 tnqpeiaeal lgagcdpelr dfrgntplhl aceqgclasv gvltqscttp hlhsilkatn
181 ynghtclhla sihgylgive llvslgadvn aqepcngrta lhlavdlqnp dlvslllkcg
241 advnrvtyqg yspyqltwgr pstriqqqlg gltlenlqml pesedeesyd teseftefte
301 delpyddcvf ggqrltl
Fig. 17 Structure and sequence of IkBα.
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Degradation of IkBα was noted within 10 min of PAC treatment and IkBα almost completely
disappeared within 4 hours and 1 hour of PAC stimulation in Huvec and Jurkat cells,
respectively. IkBα protein reappeared thereafter in the cytoplasm (Fig. 18). These findings
correspond to the increase in DNA binding of NF-κB and suggest that PAC activates NF-κB by
inducing IkBα degradation and thereby leads to rapid translocation of NF-κB from the cytoplasm
into the nucleus.
A
B
Fig. 18 IkBα degradation after PAC treatment was determined by western blotting. 4x105 Huvec (A) and 1x106
Jurkat cells (B) were treated with 100µM PAC for the time indicated and not treated as control. After
treatment, the cells were harvested and whole cell extracts (8 µg/lane) were subjected to immunoblot for
IkBα analysis.
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3.2. Analysis of PAL on TNF-α induced apoptosis
In order to compare with PAC, another component of RSM – PAL was analyzed for its effect on
TNF-α induced apoptosis. In in vitro XTT assay, PAL was shown to protect Huvec and Jurkat
cells from TNF-α cytotoxicity (Fig. 19 A, B). In morphological studies, TNF-α profoundly
sensitized Huvec cells to apoptosis in the presence of ActD, whereas 2 hours pretreatment of
PAL effectively protected the cells from death (Fig. 20).
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Fig. 19A Dose-dependent protection of Huvec cells from apoptosis was measured using XTT assay to analyze
viability of the cells. PAL was applied to the cells 2 hours before TNF-α treatment (10 ng/ml) and either
left on the cells during TNF-α treatment or washed away before or treated with PAL simultaneously with
the TNF-α treatment. As a control non treated cells and cells treated with TNF-α alone were used. In the
case of Huvec cells apoptosis was always induced by adding TNF-α together with actinomycin D (1
µg/ml). Data indicat the means of 6 individual experiments and each experiment was done in triplicate (+:
vs. Control, *: vs. TNF-α).
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Fig. 19B Dose-dependent protection of Jurkat cells from apoptosis was measured using XTT assay to analyze
viability of the cells. PAL was applied to the cells 2 hours before TNF-α treatment (10 ng/ml) and either
left on the cells during TNF-α treatment or washed away before or treated with PAL simultaneously with
the TNF-α treatment. As a control non treated cells and cells treated with TNF-α alone were used. Data
indicate the means of 4 individual experiments and each experiment was done in triplicate (+: vs. Control,
*: vs. TNF-α).
  
(a) (b) (c)
Fig.20 Morphological analysis of the effect of PAL on TNF-α induced apoptosis in Huvec cells. Pretreatment of
Huvec cells with PAL increased resistance to cell death caused by subsequent treatment with TNF-α (10
ng/ml) in the presence of actinomycin D (1 µg/ml) (a) normal Huvec cells after 16 hours of incubation in
culture medium (magnification, ×170). (b) confluent cells were treated with TNF-α for 16 hours in the
presence of actinomycin D. (c) confluent cells were pretreated with 1mM PAL for 2 hours followed by
TNF-α for 16 hours in the presence of actinomycin D.
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However, the protective effect of PAL was not suppressed by MG132, the inhibitor of IkBα
degradation (Fig. 21), suggesting a different regulatory mechanism.
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Fig. 21 MG132 did not suppress PAL protective effect. The protective effect of PAL on TNF-α induced apoptosis
was further analyzed by the use of MG132 (5 µg/ml). In XTT assay cell viability (Huvec and Jurkat cells)
was measured after adding MG132 to the cells 30 min before PAL treatment. Viability was expressed as
percentage of untreated cells. Data show the means of triplicate in a single experiment and represent 6 and
4 individual experiments in Huvec and Jurkat cells, respectively (+: vs. Control, *: vs.TNF).
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Furthermore, PAL did not induce IkBα degradation (Fig. 22), again suggesting a different mode
of action.
A
B
Fig. 22 PAL did not induce IkBα degradation. 4x105 Huvec (A) and 1x106 Jurkat cells (B) were treated with 100
µM PAL or not treated as control. After treatment, the cells were harvested and whole cell extracts (8
µg/lane) were subjected to immunoblot for analysis IkBα degradation.
Taken together these results suggested that the anti-apoptotic action of PAL may be medicated by
other signaling pathways than activation of NF-κB.
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3.3. Results of flow channel assay
3.3.1. Antioxidative capacity of Tetramethylpyrazine to RBC
When RBC were incubated with HEPES++ buffer over a total period of 72min (control group),
no significant changes of stiffness and relaxation time, respectively, were observed (Fig. 23).
Fig. 23 The effect of HEPES++ buffer on RBC stiffness and relaxation time over 72 min (control group, N=6). No
significant changes of stiffness and relaxation time were observed.
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Previous experiments showed that RBC stiffness and relaxation time did not change due to
exposure to HEPES++ with 88.5 µM TMP. Following the H2O2 treatment at 2 mM for 20 min,
RBC became significantly stiffer and, at the same time, relaxation time was reduced as compared
to control (Fig. 24). RBC stiffening (Fig. 24, upper panel). as well as relaxation time shortening
(Fig. 24, lower panel), could not be reversed by subsequent re-incubation with HEPES++. These
results indicated that the “damaging” effect of H2O2 on stiffness and relaxation time was
irreversible within 50 min of re-incubation in HEPES++ .
Fig. 24 RBC stiffness and relaxation time were markedly changed after exposing RBC to 2 mM H2O2 over a period
of 20 min. Re-incubation of RBC in HEPES++ did not reverse the H2O2-induced changes in stiffness and
relaxation time. (*: p <0.05 vs. control, ***: p<0.001 vs. control. n=13.).
46
TMP did not show any effect on RBC stiffness after the RBC had been pre-damaged with H2O2
(Fig. 25, upper panel). However, when “damaged” RBC were post-treated for 20 min with TMP,
the hydrogen peroxide-induced reduction in relaxation time returned to control levels (Fig. 25,
lower panel).
Fig. 25 Tetramethylpyrazine (TMP, 88.5 µM) effectively reverted H2O2-induced relaxation time shortening.
However, it did not reduce H2O2-enhanced RBC stiffening (*: p <0.05 vs. control, +: p <0.05 vs. H2O2.
n=12.).
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3.3.2. RBC-EC adhesion tests
Prior to the red blood cells (RBC)-endothelial cells (EC) adhesion test, the effects of Dhpl on
RBC stiffness and relaxation time were investigated (Fig. 26). When RBC were incubated with 1
mM Dhpl for 1 hour, only about 2% increase of stiffness was observed. Simultaneously, the
relaxation time was 10% enhanced. Therefore in order to exclude the marginal effects, a
concentration of 50 µM Dhpl was chosen in the RBC-EC adhesion studies.
96
98
100
102
104
106
108
110
0 0,25 0,50 0,75 1,00
Concentrations of Dhpl  (mM)
R
el
at
iv
e 
pa
ra
m
et
er
s 
 (%
)
Stiffness 
Relaxation time
Fig. 26 The effect of Dhpl on RBC mechanical parameters (n=3).
In our RBC-EC adhesion studies, the efficacy of Dhpl to inhibit hydrogen peroxide induced
damage leading to RBC-EC adhesion was compared with Vitamin E, a well-known antioxidant.
When only RBC were exposed to H2O2, a significant RBC-EC adhesion was observed. In
contrast, no enhanced adhesion was obtained when only EC were treated with H2O2. When both,
EC and RBC, were treated with H2O2, the adhesion was most pronounced (Fig. 27).
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Fig. 27 RBC adhesion to Endothelial cells (control: untreated; EC and RBC: both RBC and EC were treated with
H2O2; RBC only: only RBC were treated with H2O2; EC only: only EC were treated with H2O2). The
adhesion was expressed as remaining number of RBC after applying a wall shear stress of 0.04 Pa for 5min
to the EC monolayer. The adhesion was remarkably increased when both EC and RBC were treated with
100µM H2O2 for 30min. The data represent the mean of 5 assays (* p<0.05, ** p<0.01vs. control).
For further investigation of RBC-EC adhesion, both cell types were treated with H2O2. As shown
in Fig. 28, Dhpl inhibited the H2O2 –induced RBC adhesion to EC, at about the same molar
efficacy as Vitamin E. The extent of this inhibition was about the same at pre-treatment and post-
treatment conditions.
Fig. 28 Inhibitory effects of 50µM Dhpl or 50µM Vitamin E on H2O2 induced RBC-EC adhesion. Both RBC and
EC were exposed to 100µM H2O2 for 30min. Dhpl and Vitamin E, respectively, were applied to EC only.
Under pre-treatment conditions, the EC were incubated with Dhpl or Vitamin E, respectively, for 1h, prior
to H2O2 treatment. Whereas under post-treatment conditions, the EC were incubated with these compounds
for 1 hour after H2O2 treatment. The data represent the mean of 5 assays (**: p<0.01 vs. control, +: p <0.05,
++: p<0.01 vs. H2O2.).
4. Discussion
New drugs to treat cardio- or cerebrovascular diseases are actually urgently needed. The step
back by analysis of traditional treatments was started recently with high effort. The hope that
drugs will be detected in herbs or extracts which are used for a long time in traditional medicine
for example in china or rain forest populations is great. RSM, a traditional Chinese herb extract,
has been widely used in Chinese community to treat cardio- or cerebrovascular diseases such as
brain and myocardial infarction. In this study, we analyzed PAC and PAL, components of RSM,
for their activities in protecting cells from apoptosis, and the antioxidative effect of TMP and
Dhpl on red blood cells and endothelial cells.
4.1. Role of apoptosis in cardio- or cerebrovascular diseases
Two common vascular-disorders associated with cell death are myocaridal infarctions and stroke.
These diseases arise primarily as a result of an acute loss of blood flow (ischemia). In both
disorders, cells within the central area of ischemia appear to die rapidly as a result of necrosis.
However, outside the central ischemic zone, cells die over a more protracted time period and
morphologically appear to die by apoptosis [Cohen JJ, 1993]. Ischemia of both neurons and
cardiac myocytes in culture results in the induction of apoptosis [Tanaka M, 1994 and
Rosenbaum DM, 1994]. Agents known to be inhibitors of apoptosis in vitro have been shown to
limit infarct size in these disorders [Uyama O, 1992]. So far, the most effective method of
limiting infarct size is restoration of blood flow. Advances in medicine have developed a number
of techniques to restore blood flow rapidly in acutely occluded blood vessels. Unfortunately,
further tissue injury frequently occurs during establishment of reperfusion. Reperfusion is
associated with acute increases in free radical production and increases in intracellular calcium,
both potent inducers of apoptosis. The death of cardiomyocytes that occurs during reperfusion
bears all the hallmarks of apoptosis [Gottlieb RA, 1994].
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Our unpublished data in a rat model of focal cerebral ischemia indicated that RSM could induce a
pharmacological preconditioning in the brain, thus reduced both ischemic brain injury and
leukocyte infiltration following cerebral ischemia-reperfusion. The neuroprotective effect of
RSM might be partially mediated via an ATP-sensitive potassium channel (KATP)-linked
mechanism. To our best knowledge, a very limited number of pharmacological agents have been
reported to be able to induce pharmacological preconditioning in vivo. We believe that the
preconditioning effects of RSM are not only limited to brain, but also to other organs or tissues.
Based on the protective effects of RSM, we are interested to further investigate several
components of RSM for their protective effect from apoptosis and try to elucidate the possible
molecular mechanism of their anti-apoptotic effects.
4.2. Tumor necrosis factor alpha – mediator of apoptosis
TNFα is a cytokine mainly produced by activated macrophages and in smaller amounts by
several other cell types. It was originally identified through its capacity to suppress hemorrhagic
tumors in mice [Carswell EA, 1975]. After its isolation during the 1980s, considerable efforts
were made to understand the molecular mechanisms of the various biological effects of TNFα
[Aggarwal BB, 1984 and Pennica D, 1984]. In addition to its activity against transformed cells,
TNFα exerts various effects on different normal cell types, including hepatocytes, myocardial
cells, endothelial cells, lymphocytes, thymocytes, macrophages, polymorphonuclear neutrophils,
nephrocytes, enterocytes, and Kupffer cells [Dayer JM, 1985; Gamble JR 1985; Leist M, 1994;
Klosterhalfen B, 1997; Giardino I, 1998; Natoli G, 1998²; Fukuzuka D, 1999; Hase K, 1999;
Messmer UK, 1999 and Niwa M, 1999], and it can elicit different biological responses [Xia P,
1999]. One of these responses is the induction of apoptosis. Although tumor cells, virally infected
cells or damaged cells are frequently sensitive to TNF-α induced apoptosis, the cytotoxic effects
of TNF-α on most cells are only evident if RNA or protein synthesis is inhibited, suggesting that
de novo RNA or protein synthesis protects cells from TNF-α cytotoxicity, probably by induction
of protective genes [Wong GH, 1989; Yonehara S, 1989; Itoh N, 1991 and Karsan A, 1996].
Recent studies have identified the protective genes that are involved in transducing TNF-α death
signals [Cleveland JL, 1995 and Muzio M 1996]. The current hypothesis to explain the relation
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between TNF-α and apoptosis suggests two opposite signaling pathways: TNF-α produces
positive survival signals and simultaneously negative apoptotic signals. The balance of those
pathways will regulate the fate of cells in response to TNF-α stimulation [Nagata S, 1997]. The
molecular mechanisms of TNF-α induced cell death have been extensively studied, and recent
clinical evidence has shown that serum levels of TNF-α are increased after myocardial infarction.
Moreover, TNF-α directly decreases animal and human myocardial contractility in dose-
dependent fashion [Cain BS,1999]. Therefore, TNF-α was used in the present studies to elicit
cytotoxicity, and Huvec as well as Jurkat cells were chosen as an in vitro system to analyze cell
protective action of PAC and PAL.
4.3. PAC and PAL protect cells from induction of cell death
The morphological studies have shown that TNF-α (16 h, 10 ng/ml) resulted in extensive loss of
viability in Huvec cells and less cell death occurred by preincubation with 1mM PAC or PAL for
2 hours. The data provided a first impression that PAC and PAL could protect Huvec cells from
TNF-α induced cytotoxicity. Further, XTT assays were performed to quantify the number of cells
undergoing apoptosis. The assay is based on the cleavage of the yellow tetrazolium salt XTT to
form an orange formazan dye by metabolic active cells [Gerlier D,1986]. In cell viability XTT
assays, PAC and PAL were shown to be potent inhibitors of TNF-α induced apoptosis in both
Huvec and Jurkat cells. Since XTT assays are based on the mitochondrial dehydrogenase activity
of metabolic active cells, an increase in number of living cells results in an increase in the overall
activity of mitochondrial dehydrogenase [Berridge MV, 1997]. These data of cell viability assays
suggested that PAC and PAL may “switch on” positive signals which could protect cells from
death. This positive signals might prevent the induction of apoptosis by reducing the amount or
activity of crucial cell death effector proteins to harmless levels. Alternatively, they may inhibit
cell death by boosting the activity of protective, anti-apoptotic proteins.
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4.3.1. Transcription factor NF-κB
To a large extent, gene expression is controlled by the frequency of transcriptional initiation at
the promoter. Initiation of transcription is preceded by the formation of a large nucleoprotein
complex containing promoter DNA, basal transcription factors, upstream activator proteins, and a
variety of other proteins. In many cases, the rate at which transcription initiates is limited by the
availability or activity of the DNA-binding upstream activators. One such upstream activator is
the transcription factor NF-κB, whose DNA-binding activity and nuclear/cytoplasmic distribution
are controlled by the IκB inhibitor proteins. In unstimulated cells, NF-κB is held in the
cytoplasm, in a form that is unable to bind DNA, by the inhibitory IκB proteins. Exposure of
cells to a wide variety of stimuli results in release of the transcription factor from the IκB
proteins, allowing the active DNA-binding form of the transcription factor to translocate to the
nucleus, where it binds to its recognition sites in the upstream regions of a wide variety of genes
that respond to immune and inflammatory response [Hay RT,1993 and Liou HC, 1993 ](Fig. 29).
Fig. 29 NF-κB signaling pathway.
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NF-κB is a dimer of proteins that share a highly conserved region known as the Rel homology
domain which contains the sequences responsible for DNA binding, dimerization, and nuclear
localization. The 11-bp binding site of NF-κB is recognized by the protein in an unusual way
involving base and backbone contacts with the DNA over one complete helical turn [Clark L1,2,
1989]. In humans, the family of proteins consists of p50 [Ghosh SA, 1990 and Kieran M, 1990],
p52 [Bours V, 1992; Neri AC, 1992 and Schmid RM, 1991], p65 [Nolan GP, 1991 and Ruben
SM, 1991], c-Rel [Wilhelmsen KC, 1984], and RelB [Ryseck RP, 1992]. Although it appears that
almost all combinations of homo- and heterodimers can exist, the typical form of NF-κB, that is
activated in response to extracellular signals, is composed of a heterodimer of p50 and p65. p50
represents the N-terminal region of a p105 precursor from which it is processed by a pathway
thought to involve ubiquitinylation of the protein [Palombella VJ, 1994]. The C-terminal region
removed from p105 contains multiple repeats of a 30- to 35-aminoacid sequence present in the
erythrocyte protein ankyrin [Lux SE, 1990] and found in all proteins with IκB activity [Gilmore
TD, 1993]. In lymphoid cells, the C-terminal region of p105 has been identified as an
independent entity known as IκB γ [Inoue JI, 1992 and Liou HC, 1992] that preferentially
inhibits the DNA-binding activity of p50 homodimers. In the p105 precursor molecule, the C-
terminal region is thought to function as a cis-acting inhibitor of p105 DNA-binding activity
[Henkel T,1993]. Although p50 does not possess a transcriptional activation domain, its p65
partner does have an acidic activation domain that accounts for the transcriptional activity of the
NF-κB heterodimer [Fujita T, 1992 and Schmitz ML, 1991]. NF-κB activity is regulated by its
association with the inhibitor subunit(s) of IkB [Baeuerle PA, 1988 and Haskill S, 1991]. The IkB
family of proteins is defined by its ability to interact with NF-κB/Rel subunits and by the
presence of between five and seven repeats of a 33 amino acid sequence termed the ankyrin motif
[Beg AA, 19931]. The ankyrin motif mediates sequestration of NF-κB in the cytoplasm, possibly
in association with cytoskeletal proteins [Rosette C, 1995]. IκBα [Haskill S, 1991] is the most
extensively studied protein in this family. When cells are exposed to stimuli which activate NF-
κB, IκBα becomes hyperphosphorylated, detectable in immunoblots as a slowly migrating form,
sensitive to phosphatase treatment [Beg AA, 19931; Brown K, 1993; Cordle SR, 1993; Henkel T,
1993; Mellits KH, 1993 and Sun SC, 1993]. The hyperphosphorylation occurs at the N-terminus
of the molecule and is a signal for subsequent ubiquitination and degradation by the 26S
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proteasome. Neither hyperphosphorylation [Traenckner EB-M, 1994 and Alkalay I, 19951] nor
ubiquitination [Chen Z, 1995] impairs the ability of IκBα to associate with NF-κB. Moreover,
only hyperphosphorylated IκBα is a target for degradation by an in vitro reconstituted ubiquitin-
proteasome system [Alkalay I, 19952]. Phosphorylation and subsequent degradation via the
ubiquitin-proteasome degradation pathway are therefore key elements in NF-κB liberation and
nuclear translocation [Beg AA, 1993²; Brown K, 1993; Traenckner EB-M, 1994; Alkalay I,
199512; Chen Z, 1995].
Recent studies have described a role for NF-κB in blocking apoptosis which is induced by tumor
necrosis factor. For instance, Baltimore’s group treated cells taken from NF-κB knockout mice
with TNF, and compared their response to that of cells from normal mice [Beg AA and Baltimore
D, 1996]. The normal cells survived, but those lacking NF-κB died. Another proof of the
essential role of NF-κB comes from experiments in which NF-κB activity is inhibited by
antibodies or by an inhibitory protein that triggers apoptosis [ Van-Antwerp DJ, 1996; Wang CY,
1996 and Bach FH, 1997]. Baldwin’s and Verma’s groups introduced into a variety of cultured
tumor and nontumor cells a mutant form of IκB that acts as a “super-repressor”, keeping NF-κB
irreversibly shackled in the cell’s cytoplasm. With NF-κB out of the picture, TNF could kill all
the cell types. Therefore, it appears that NF-κB has a general role in preventing apoptosis.
4.3.2. Activation of NF-κB by PAC but not by PAL
NF-κB has been recently described as one survival signaling pathway to counteract the
cytotoxicity of the apoptotic pathway and then suppress apoptotic cascades in diverse cell types.
Thus, an important question was raised: whether activation of NF-κB plays a role in PAC
protective effect against apoptosis? This speculation was supported by our observations in
different experimental approaches.
At first, in Huvec and Jurkat cells the NF-κB pathway was efficiently activated by PAC, as
evidenced by luciferase assays for measuring reporter gene and gel shift assays for measuring
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DNA-binding of nuclear extracts. 30 min incubation of PAC led to strong increase of NF-κB
reporter gene and DNA-binding in both cell types (Fig. 9, 13). Previous studies have
demonstrated that the primary form of NF-κB is retained as a latent form in the cytoplasm by its
inhibitory protein IκB. Thus our western blotting experiment further confirmed that PAC
activated NF-κB due to the degradation of IκBα, the NF-κB endogenous cytosolic inhibitor.
IκBα was rapidly degraded after PAC stimulation and almost completely disappeared within 4 h
and 1 h of PAC stimulation in Huvec and Jurkat cells, respectively. IκBα protein reappeared
thereafter in the cytoplasm (Fig. 18). Since proteolytic degradation of IκBα is essential for
activation of NF-κB [Palombella VJ, 1994; Siebenlist U, 1994; Traenckner EB-M, 1994 and Lin
YC, 1995], when degradation of IκBα is blocked, activation of NF-κB is prevented. Approaches
to inhibit activation of NF-κB include gene therapy delivery of super-repressor IκBα or use of a
variety of agents to block NF-κB function such as proteasome inhibitors. Proteasome inhibitors
inhibit activation of NF-κB by blocking the degradation of IκBα and subsequent nuclear
translocation of NF-κB/Rel protein [Henkel T, 1993 and Marui N, 1993]. To further determine
PAC function when activation of NF-κB is blocked, MG132, a potential proteasome inhibitor,
was used in this study. Treatment of cells with MG132 resulted in failure of PAC to protect from
apoptosis triggered by TNFα (Fig. 14). An alternative approach to block NF-κB in this study is
use of a NF-κB inhibitory peptide, which contains a cell membrane-permeable motif and nuclear
localization sequence of NF-κB p50. It can directly inhibit nuclear translocation of NF-κB /Rel
complexes in intact cells. Addition of NF-κB inhibitory peptide resulted in a loss of PAC
protection from apoptosis (Fig. 16). Taken together, activation of NF-κB was shown to be crucial
for the anti-apoptotic effect of PAC.
Recent studies have shown that NF-κB controls the expression of IκBα by means of an inducible
autoregulatory pathway [Sun SC, 1993] (Fig. 30).
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Fig. 30 Auto-regulatory pathway of the NF-κB/ IkBα. Activators of NF-κB trigger signal transduction cascades that
result in hyperphosphorylation of IkBα (steps 1-2). Hyper-phosphorylation is a signal for IkBα
ubiquitination (step 3) and subsequent degradation by the 26S proteasome (step 4). Following IkBα
degradation, NF-κB translocates to the nucleus and activates NF-κB-dependent cytokine genes. Also
activated are components of the NF-κB pathway such as IkBα, NF-κB1 (p105) and NF-κB2 (p100) (step 5).
Newly synthesized IkBα can retain NF-κB in the cytoplasm or may move to the nucleus and dissociate NF-κB/DNA complexes, thereby exerting a direct inhibition on gene expression. Newly synthesized p105 and
p100 proteins also retain NF-κB proteins such as Rel A in the cytoplasm (step 6). P105 and p100 are
proteolytically cleaved to generate p50 and p52 respectively (step 7-8), which can localize to the nucleus or
be retained in the cytoplasm, complexed to IkBα.
After degradation of IκBα, active DNA-binding form of NF-κB translocates to the nucleus,
where it binds to DNA recognition sites in the promoter of a wide variety of genes, including
IκBα gene, and activates gene expression. The cytoplasmic reservoir of IκBα is then completely
replenished by NF-κB-induced de novo synthesis of IκBα protein [LeBail O, 1993 and Chiao PJ,
1994]. Newly synthesized IκBα protein appears transiently in the nucleus, where it terminates
DNA-binding and transcription [Arenzana-Seisdedos F, 1995]. Our results of immunoblotting
and gel shifts are in complete agreement with this autoregulatory signal pathway.
In this study, in order to compare it to PAC , PAL as another component of RSM was analysed
for its effect on activation of NF-κB. In in vitro experiment PAL was shown to protect Huvec and
Jurkat cells from cytotoxicity triggered by TNFα. Nevertheless treatment of MG132 could not
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inhibit the PAL protection from apoptosis triggered by TNFα. Additionally PAL did not induce
IκBα degradation (Fig. 20-22). These results imply that the anti-apoptotic action of PAL is
medicated by another molecular mechanism instead of activation of NF-κB. Moreover, from the
structural difference between PAC and PAL, it might suggest that the carboxylic group of PAC
acts as an essential constituent to induce NF-κB activation (Fig. 2).
4.4. Investigation of antioxidative capacity of TMP and Dhpl by flow
channel techniques
Two different applications of flow channel techniques were used to investigate the antioxidative
capacity of natural compounds, plant extracts and in particular Chinese herbs. The Microscopic
Photometric Monolayer Technique is capable to precisely quantitate RBC stiffening and
relaxation time shortening due to hydrogen peroxide damage over time [Artmann GM, 1995].
This tool has been applied to investigate the anti-oxidative protective capacity of TMP. RBC
treated with hydrogen peroxide exhibited significantly attenuated relaxation times.
Simultaneously, the RBC stiffness increased. These changes were irreversible during re-
incubation with HEPES++. Reduced overall RBC elongation after hydrogen peroxide treatment
have been observed earlier based on evaluation of freely suspended RBC sheared in a cone-plate
system [Hebbel RP, 1990]. Even though the cone-plate system is different in many aspects from
the flow channel technique used here, the data support the validity of the hydrogen peroxide
damaging model used in our experiments.
4.4.1. Antioxidative capacity of Tetramethylpyrazine to RBC
TMP, as tested for its antioxidative capacity, reversed the hydrogen peroxide-induced shortening
of relaxation time. Simultaneously the RBC stiffness was not reversed and osmotic effects of
TMP were excluded. Thus, TMP may have partially re-established a normal RBC membrane
viscosity after H2O2 pre-damaging. It is known, that hydrogen peroxide enhances the interactions
of hemoglobin with the RBC cytoskeleton namely with spectrin which in turn leads to an
enhanced overall membrane viscosity [Rice-Evans C, 1986]. As the underlying mechanism we
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hypothesize, that TMP applied to hydrogen peroxide pre-damaged RBC may partially reverse
hydrogen peroxide mediated hemoglobin-spectrin complexes, thus, leading to a normalization of
the membrane viscosity.
RBC stiffening is related to the elasticity of the RBC cytoskeleton. The RBC’s cytoskeleton
represents an extensive and complex self-associating network of proteins. Cross-linking of
cytoskeletal proteins due to peroxidation in particular leads to a decrease of RBC deformability
[Nicolson GL, 1973; Girotti AW, 1984; Schrier SL, 1985; Snyder LM, 1985 and Oroszlan G,
1986]. TMP did not reverse hydrogen peroxide induced RBC stiffening, indicating that TMP did
not reverse hydrogen peroxide cytoskeletal crosslinkings.
4.4 2. Protection of Dhpl from H2O2 induced RBC-EC adhesion
In a further approach the flow channels technique was used to study RBC-EC adhesion as
induced with hydrogen peroxide. A similar hydrogen peroxide based in vitro model was
established previously [Wang L, 1995]. The authors reported on enhanced adhesion of RBC of
patients with cerebral thrombosis to cultured human umbilical vein endothelial cells treated with
H2O2 using a flow chamber system. In our study, the inhibitory capacity of Dhpl was compared
with Vitamin E, a well-known antioxidant. Dhpl is used in Chinese traditional Medicine to cure
ischemic cerebral vascular diseases and ischemic cardiovascular diseases [Zhang ZH, 1994 and
Li DY, 1995]. The exposure of only RBC with hydrogen peroxide led to a significant adhesion
(about two-fold) to cultured EC monolayers. Whereas, no enhanced RBC adhesion occurred
when only EC were treated with hydrogen peroxide. When both EC and RBC were treated with
H2O2 a remarkable (about three-fold) RBC-EC adhesion was observed. The results imply that
modifications in surface properties due to hydrogen peroxide on both RBC and EC were required
to induce a major RBC-EC adhesion. If an oxidative event in vivo occurs, it usually would affect
both cell types. Thus, damaging of both RBC and EC in this in vitro model should fit best to the
in vivo situation. Dhpl as well as Vitamin E both at 50 µM protected from oxidatively induced
RBC-EC adhesion to the same extend. It did not matter whether the compounds were added
before damaging or after, respectively. The mechanism of protection observed when the drugs
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were added before hydrogen peroxide damaging might be addressed to a direct free radical
scavenging effect of antioxidants dissolved in the EC membrane. Although very interesting from
a clinical point of view, the protection mechanism of drugs applied after damaging must be
addressed in future studies.
In summary, flow channel techniques as used here in terms of cellular bioassays could become
useful tools for evaluating antioxidative active substances in particular of Chinese herbs, plant
extracts and other substances. The fact, that extracts do not contain single molecules but a variety
of sub-components rather underlines the need of studies on a cellular level. Of particular
advantage in terms of creating an antioxidative protection scale is the use of drugs (Vitamin E)
known for a specific effect as basis for efficacy comparisons.
4.5. Future perspectives
The present study provides a mechanistic explanation for the anti-apoptotic effect of PAC and
indicates that this effect involves degradation of IkBα and subsequent activation of NF-κB.
Further studies are required to test whether PAC could be useful in preventing apoptotic cell
death in vivo resulting from cardiovascular or cerebrovascular diseases. In addition, efforts could
be made in the following fields to provide futher evidence for PAC induced NF-κB activation.
• Many signal transduction pathways resulting in NF-κB activation culminate in a serine
phosphorylation of IkBα on residues 32 and 36 [Brown K, 1995; Traenckner EB, 1995;
DiDonato JA, 1997; Mercurio F, 1997 and Regnier CH, 1997] and trigger its ubiquitination-
dependent degradation [Alkalay I2, 1995; Chen Z, 1995 and Scherer DC, 1995]. Therefore, it
could be analysed in the future whether PAC induces serine phosphorylation of IkBα.
• A specific serine-protein-kinase activity responsible for IκBα phosphorylation has been
identified as a large cytoplasmic multisubunit complex (700-900 kDa); two kinase subunits
(IKK1/α and IKK2/β) and a structural component (NEMO/IKKγ/IKKAP) have been cloned
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[Scheidereit C and Israël A, 2000]. IKK complex could be then investigated to elucidate the
mechanisms contributing to the exquisite regulation of NF-κB activity.
• Active DNA-binding form of NF-κB translocates to the nucleus, where it binds to its
recognition sites in the upstream regions of a wide variety of genes that respond to immune and
inflammatory signals. Therefore, such NF-κB regulative genes , e.g. ICM-1, VCAM-1 and IL-
8 could be chosen to check if PAC also activates these genes.
Although PAL also shows cell protection from TNF-induced cytotoxicity, the molecular basis of
this effect is not yet clear. In order to identify its mechanism, other anti-apoptotic pathways
except NF-κB need to be analyzed in the future.
5. Summary
The Chinese herb, Radix Salviae Miltiorrhizae (RSM), is being used in traditional Chinese
medicine as a treatment for cardiovascular and cerebrovascular diseases. Several components of
the plant extract from Salvia Mitorrhiza Bunge have been determined previously, two of which
are protocatechuic acid (PAC) and protocatechuic aldehyde (PAL). Since anti-apoptotic therapies
have been proposed to limit tissue damage in cardiovascular and cerebrovascular diseases, PAC
and PAL effects on cell protection from apoptosis were investigated in this thesis. XTT assays
were first used to quantify cell viability. We found that PAC and PAL inhibited TNF-α induced
apoptosis of human umbilical vein endothelial cells (Huvec) and Jurkat cells in a concentration of
100 µM and 1mM respectively, when applied 2 hours prior to TNF-α exposition. To investigate
molecular consequences on cellular signal transduction pathways, NF-κB reporter gene and DNA
binding activities were investigated by luciferase assay and gel shift assay. Degradation of IkBα
was determined by western blotting. The molecular studies revealed that PAC activated NF-κB
with a maximal effect after 30 min of treatment. Inhibition of NF-κB action by MG132 and NF-
κB inhibitory peptide suppressed the anti-apoptotic effect of PAC. Further, degradation of IkBα
occurred in response to PAC treatment. Our results provide evidence that activation of NF-κB
plays an important role in mediating the anti-apoptotic effect of PAC on HUVEC and Jurkat
cells. Nevertheless, PAL protection from apoptosis triggered by TNF-α could not prevented by
the treatment of MG132. Additionally, PAL did not induce IκBα degradation. The results
implied that the anti-apoptotic action of PAL may be mediated by a molecular mechanism other
than activation of NF-κB.
In addition, a computer controlled flow channel system (Elias-c-) was tested in this thesis to
study antioxidative capacities of herbal medicine. Effects of herbal extracts and single
components on oxidatively impaired red blood cell (RBC) stiffness and relaxation time as well as
on oxidative damage (H2O2, 2 mM) induced RBC-endothelial cell (EC) adhesion were
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investigated. Following H2O2 treatment (20 min), RBC became significantly stiffer and the
relaxation time was reduced as compared with control. These changes were irreversible after re-
incubating oxidatively damaged RBC in HEPES buffer. However, when oxidatively damaged
RBC were re-incubated with 88.5 µM Tetramethylpyrazine (TMP), the H2O2-induced reduction
in relaxation time turned back to control levels whereas the RBC stiffening did not. As
mechanism we hypothesize, that TMP applied to hydrogen peroxide damaged RBC may partially
reverse the hydrogen peroxide mediated formation of hemoglobin-spectrin complexes possibly
leading to a normalization of the membrane viscosity. In the RBC-EC adhesion tests, a maximum
(about three-fold as compared to control) increase in RBC-EC adhesion was obtained when both
RBC and EC were treated with H2O2. This increase in adhesion was almost completely inhibited
by 50 µM 3,4-dihydroxyphenyl lactate (Dhpl), when applied either prior to or after treatment with
H2O2. The mechanism of the protection may be addressed in part to a direct free radical
scavenging effect of antioxidants dissolved in the EC membrane. From a methodological point of
view, the Elias-c in combination with appropriate cell types and experimental designs can be seen
as a cellular bioassays to test herbal extracts with high laboratory efficacy.
6. Zusammenfassung
Das in der traditionellen chinesischen Medizin verwendete Extrakt Radix Salviae Miltiorrhizae
(RSM) wird zur Behandlung von Herzkreislauf und zerebrovaskulären Krankheiten benutzt.
Einige Bestandteile des Pflanzenextraktes von Salviae Mitorrhiza Bunge sind bereits extrahiert
und analysiert worden. Zwei dieser Komponenten sind Protocatechuic Säure (PAC) und
Protocatechuic Aldehyd (PAL). Es wird angenommen, daß anti-apoptotische Therapien die
Gewebeschäden bei Herzgefäßkrankheiten sowie zerebrovaskulären Krankheiten reduzieren. In
dieser Arbeit wurde daher die zellprotektive Wirkung von PAC und PAL, im besonderen
Hinblick auf Apoptose, untersucht. XTT-Assays wurden verwendet, um den Prozentsatz lebender
Zellen unter verschiedenen Bedingungen quantitativ zu bestimmen. Menschliche Nabelschnur
Endothelzellen sowie Jurkat Zellen wurden 2 Stunden mit PAC (100 µM) bzw. PAL (1 mM)
inkubiert. Es konnte gezeigt werden, daß PAC und PAL die TNF-α induzierte Apoptose von
menschlichen Nabelschnur Endothelzellen (Huvec) und Jurkat Zellen reduziert. Um molekulare
Effekte auf die zelluläre Signaltransduktion zu untersuchen, wurden NF-κB Reportergen und
DNA Bindungsaktivitäten mittels Luciferase Assays sowie Gel Shift Assays bestimmt. Die
Degradation von IkBa wurde durch Western Blotts untersucht. Die molekularen Studien zeigten,
daß NF-κB durch PAC aktiviert wurde. Der maximalen Effekt trat nach 30-minütiger
Vorbehandlung der Zellen mit PAC auf. Hemmung der NF-κB Aktivität durch MG132 und ein
NF-κB hemmendes Peptid unterdrückten den anti-apoptotischen Effekt von PAC. Weiterhin trat
eine Degradation von IkBα infolge der Behandlung mit PAC auf. Unsere Ergebnisse liefern
Hinweise darauf, daß die Aktivierung von NF-κB bei der anti-apoptotischen Wirkung von PAC
auf Huvec und Jurkat Zellen eine wichtige Rolle spielt. Allerdings wurde die protektive Wirkung
von PAL gegen Apoptose nicht von MG132 beeinflusst. Auch induzierte PAL keinen Abbau von
IκBα in den Zellen. Diese Resultate deuten darauf hin, daß die anti-apoptotische Wirkung von
PAL durch andere molekulare Mechanismen als durch die Aktivierung von NF-κB vermittelt
wird.
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Zusätzlich wurde ein computergesteuertes Flußkanalsystem zur Bestimmung zellulärer
rheologischer Parameter (Elias-c -) verwendet, um die antioxidative Wirkung von chinesischen
Naturheilmitteln zu untersuchen. Dabei interessierten uns die Effekte der Kräuterextrakte sowie
einiger ihrer Bestandteile auf die durch oxidative Schädigung veränderten rheologischen
Parameter der Zellen. Als Parameter wurde die Steifigkeit und die Relaxationszeit roter
Blutkörperchen (RBC) sowie die durch oxidative Schädigung (H2O2, 2 mM) induzierte Adhäsion
von roten Blutkörperchen Endothelzellen gemessen. Nach Inkubation der roten Blutkörperchen
mit H2O2 (20 min), zeigten die Zellen eine signifikant höhere Steifigkeit. Weiterhin war die
Relaxationszeit im Vergleich zu Kontrollversuchen reduziert. Diese Änderungen der
rheologischen Parameter waren irreversibel, nachdem die oxidativ geschädigten RBCs in Hepes
Puffer reinkubiert wurden. Wurden die Zellen jedoch in Puffer mit 88.5 µM Tetramethylpyrazine
(TMP) reinkubiert, ging die Änderung der Relaxationszeit auf das Niveau der Kontrolle zurück,
während sich kein Effekt auf die Steifheit der Zellen zeigte. Als möglichen Mechanismus
nehmen wir an, daß TMP die durch Wasserstoffperoxid verursachte Bildung von Spektrin-
Hömoglobin-Komplexen teilweise aufhebt, was möglicherweise zu einer Normalisierung der
Membranviskosität führen könnte. In den RBC-EC Adhäsionstests wurde eine maximale (über
dreifache verglichen mit der Kontrolle) Zunahme der Adhäsion, bei mit H2O2 behandelten roten
Blutzellen und Endothelzellen festgestellt. Diese Adhäsion wurde fast vollständig durch 50 µM
3,4-dihydroxyphenyl lactate (Dhpl) inhibiert, wenn diese Komponente entweder vor oder nach
der Behandlung der Zellen mit H2O2 zugegeben wurde. Der Mechanismus dieser protektiven
Wirkung könnte teilweise einem Effekt von Dhpl als Radikalfänger von in der Zellmembran
gelösten Oxidantien zugeschrieben werden. Von einem methodischen Gesichtspunkt aus kann der
Elias-c im Verbindung mit bestimmten Zellenarten und experimentellen Designs als zellulärer
Bioassay verwendet werden, um die Wirkung von Kräuterextrakten mit hoher Effizienz im Labor
zu prüfen.
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8. Abbreviations
ActD Actinomycin D
Amp Ampicillin
APS Ammoniumpersulfat
BCIP/NBT 5-Bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium
tablets
d H2O Distilled water
Dhpl 3,4-dihydroxyphenyl lactate
DTT Dithiothreitol
EC Endothelial cells
EDTA Ethylendiamintetraacetat
EGTA Ethylene glycol-O,O’-bis (2-aminoethyl)-N,N,N’,N’,-
Tetraacetic acid
EMSA Electrophoretic Mobility-Shift Assay
H2O2 Hydrogen peroxide
IκB Inhibitor of NF-κB
NF-κB Nuclear transcription factor kappa B
NP-40 Nonidet P40
PAA Polyacrylamid
PAC Protocatechuic Acid
PAL Protocatechuic Aldehyde
PBS Phosphate buffered saline
RBC Red blood cells
RSM Radix Salviae miltiorrhizae
TEMED N,N,N’,N’,-Tetramethylethylendiamin
TMP Tetramethylpyrazine
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TNFα Tumor necrosis factor-alpha
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